Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression (HEALED)

March 25, 2026 updated by: Kirstin Leitner, University of Pennsylvania
The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.

Study Overview

Status

Recruiting

Detailed Description

Healing at Home (H@H) 2.0 is a comprehensive technology-based postpartum support program which provides 24/7 support to individuals through use of an SMS chatbot for six weeks postpartum. This will be a randomized controlled trial (RCT) with an intervention arm consisting of patients who are planning to be discharged at routine timing (as determined by their clinical team) with access to H@H 2.0 postpartum SMS chatbot platform and a control arm which consists of usual postpartum care.

Study Type

Interventional

Enrollment (Estimated)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Recruiting
        • Hospital of the University of Pennsylvania
        • Contact:
        • Principal Investigator:
          • Kirstin Leitner, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
  • Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
  • Able to speak, read and write English
  • Age ≥18
  • Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
  • Completion of clinically administered EPDS during inpatient stay
  • Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery

Exclusion Criteria:

  • Unable to provide informed consent
  • Baby not discharged with mother at postpartum discharge
  • Does not have access to a mobile phone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of care
Routine postpartum care.
Experimental: Healing @ Home Program (H@H 2.0)
Routine postpartum care and the use of an algorithm-based text message support program for six weeks.
Healing @ Home 2.0 is a clinically used comprehensive technology-based postpartum support program, which provides 24/7 support to individuals through use of a text message based chatbot for six weeks postpartum. Content of H@H 2.0 includes anticipatory guidance regarding physical recovery, infant care and feeding, clinical algorithms to respond to urgent patient needs.
Other Names:
  • Penny the Chatbot
  • H@H 2.0
  • W2H

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edinburgh Postnatal Depression Scale (EPDS) Screening Score
Time Frame: At 6 weeks postpartum
Scores from the validated EPDS screening tool will be calculated using standard scoring criteria for each of the 10 items. A score of 9 or greater or indication of suicide ideation will be used to indicate a positive depression screen.
At 6 weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum visit attendance
Time Frame: Up to 3 months postpartum
Whether or not the patient attended their routine postpartum visit which should occur around the 6-week postpartum mark. We will accept routine postpartum visits up to 12-weeks postpartum.
Up to 3 months postpartum
Count of unscheduled emergency room/postpartum triage visits
Time Frame: Up to 6 weeks postpartum
The number of unscheduled visits, reason for visit, whether or not patient was admitted to hospital in the first 6 weeks postpartum will be counted
Up to 6 weeks postpartum
Mode of feeding
Time Frame: At baseline and 6 weeks postpartum
Patient asked mode of feeding at two time points. Options are exclusively breastfeeding, formula feeding only, or both breast and formula feeding.
At baseline and 6 weeks postpartum
Scores of self-efficacy in infant care
Time Frame: At baseline and at 6 weeks postpartum
Scores from the validated Self-efficacy in the Nurturing Role (SENR) tool will be calculated using Likert scale scoring criteria for each of the 16 items. Negative items are reverse-scored such that higher scores on the items always reflect greater self-efficacy.
At baseline and at 6 weeks postpartum
Knowledge of postpartum warning signs
Time Frame: At baseline and at 6 weeks postpartum
Using a question from the Pregnancy Risk Assessment measure survey (PRAMS) to ask patients to identify warning signs of complications that can occur after birth
At baseline and at 6 weeks postpartum
Score of Postpartum sleep: quality
Time Frame: At baseline and at 6 weeks postpartum
One question Likert scale ranking quality of sleep from terrible to excellent.
At baseline and at 6 weeks postpartum
Postpartum sleep: hours
Time Frame: At baseline and at 6 weeks postpartum
Average number of hours slept in the past 7 days.
At baseline and at 6 weeks postpartum
Postpartum pain score
Time Frame: 24 hours prior to discharge from hospital
Scores from a 10-item question from the validated Brief Pain Inventory short form will be calculated using Likert scale scoring criteria with scores ranging from 0-100. Higher scores mean higher pain.
24 hours prior to discharge from hospital
Social support and maternal functioning score
Time Frame: At 6 weeks postpartum
Scores from the validated Barkin Index of Maternal Functioning tool will be calculated using Likert scale scoring criteria for each of the 20 questions. The total score ranges from 0 to 120, with a score of 120 representing perfect functioning.
At 6 weeks postpartum
Implementation outcome: Acceptability of Intervention Measure
Time Frame: At 6 weeks postpartum
4-item Likert scale where scores can range from 4 to 20. High scores indicate higher acceptability. Given to the intervention group only.
At 6 weeks postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kirstin Leitner, MD, University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

March 8, 2025

First Submitted That Met QC Criteria

March 13, 2025

First Posted (Actual)

March 14, 2025

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression, Postpartum

Clinical Trials on Healing @ Home Program (H@H 2.0)

Subscribe